Scarica l'app Stockscreener
87.61
0.14%
0.12
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$87.49
Aprire:
$87.57
Volume 24 ore:
9.08M
Relative Volume:
0.84
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+1.55%
1M Prestazione:
+5.21%
6M Prestazione:
-5.25%
1 anno Prestazione:
-13.24%
Intervallo 1D:
$86.73
$87.87
Intervallo di 1 settimana:
$85.50
$88.64
Portata 52W:
$66.66
$105.47
Spdr Biotech Etf Stock (XBI) Company Profile
Nome
Spdr Biotech Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta XBI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XBI
Spdr Biotech Etf
|
87.61 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
313.69 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
637.10 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
640.06 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
246.70 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
566.37 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Biotech Etf Borsa (XBI) Ultime notizie
6 Best Health Care Funds and ETFs for 2025 | Investing - US News Money
(XBI) Trading Advice - news.stocktradersdaily.com
Cerity Partners LLC Has $1.51 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by Cerity Partners LLC - Defense World
Envestnet Asset Management Inc. Sells 16,015 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
M&T Bank Corp Has $446,000 Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Stake Lowered by Stratos Wealth Partners LTD. - Defense World
SPDR S&P Biotech ETF Options Spot-On: On July 15th, 99,099 Contracts Were Traded, With 717.92K Open Interest - 富途牛牛
Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now. - Barron's
XBI ETF: Riding the Pharma-Biotech Consolidation Wave - AInvest
Biotech Stocks Are Ready to Rebound. 3 to Watch Now. - Barron's
(XBI) Investment Analysis and Advice - news.stocktradersdaily.com
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Biotech ETFs: Navigating Growth and Stability in a Volatile Landscape - AInvest
Biotech Looks Ready To Run, But ETFs, Which One? IBB Vs. XBI - Seeking Alpha
How to Take Advantage of moves in (XBI) - news.stocktradersdaily.com
Learn to Evaluate (XBI) using the Charts - news.stocktradersdaily.com
Dynamic Advisor Solutions LLC Takes $825,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
3,309 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Bought by Park Avenue Securities LLC - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by GAMMA Investing LLC - Defense World
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - sharewise
Long Term Trading Analysis for (XBI) - news.stocktradersdaily.com
Should You Invest in the iShares Biotechnology ETF (IBB)? - sharewise
How Is Vertex Pharmaceuticals’ Stock Performance Compared to Other Biotech Stocks? - The Globe and Mail
Northern Trust Corp Reduces Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Nasdaq
Hedge Funds Question Market Rally, Build Massive Short WallAmer Sports (NYSE:AS), First Solar (NASDAQ:FSLR) - Benzinga
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - Nasdaq
Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment - Benzinga
Zacks Investment Ideas feature highlights: Alibaba, JD.com, SPDR S&P Biotech ETF, Merck and Microsoft - TradingView
XBI: Some Tariff Relief Right Now, But Macro Risks Remain In Biotech (NYSEARCA:XBI) - Seeking Alpha
Optimism is Back for Biotech Stocks. This Time, It Could Last. - MSN
MBB Leads With $1.2B Gain as Markets React to UK Trade Deal - TradingView
XBI, EXAS, ALNY, NTRA: Large Outflows Detected at ETF - Nasdaq
(XBI) Investment Analysis - news.stocktradersdaily.com
XBI, Biotech Stocks Retreat: Buy, Hold or Sell? - ETF.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
SPDR S&P Biotech ETF Target of Unusually High Options Trading (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF Options Spot-On: On May 6th, 140.63K Contracts Were Traded, With 658.97K Open Interest - 富途牛牛
Optimism Is Back for Biotech Stocks. This Time, It Could Last. - Barron's
Renaissance Technologies LLC Purchases Shares of 5,500 SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Should You Invest in the VanEck Biotech ETF (BBH)? - Nasdaq
ETFs That Outperform the S&P 500: ARKK, VGT, IWF, XBI - Markets.com
(XBI) On The My Stocks Page - news.stocktradersdaily.com
Alliancebernstein L.P. Makes New Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Spdr Biotech Etf Azioni (XBI) Dati Finanziari
Non sono disponibili dati finanziari per Spdr Biotech Etf (XBI). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.43%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):